microMend Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $200K

  • Investors
  • 21

microMend General Information

Description

Developer of wound closure product designed to offer a new alternative to sutures and staples for skin closure. The company's product has the added feature of tiny micro staples that assist it in achieving similar holding strength to sutures and close wounds, enabling medical practitioners to close surgical incisions, lacerations and skin tears.

Contact Information

Website
www.micromendskinclosure.com
Formerly Known As
Marco Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1525 11th Avenue
  • Seattle, WA 98122
  • United States
+1 (877) 000-0000
Primary Industry
Medical Supplies
Vertical(s)
LOHAS & Wellness, HealthTech
Corporate Office
  • 1525 11th Avenue
  • Seattle, WA 98122
  • United States
+1 (877) 000-0000

microMend Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

microMend Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 28-Jun-2024 $200K 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 07-Dec-2021 000.00 000.00 000.00 Completed Generating Revenue
4. Accelerator/Incubator 00.000 Completed Generating Revenue
3. Later Stage VC (Series A1) 02-Mar-2017 00000 00.000 00.00 Completed Generating Revenue
2. Early Stage VC (Series A) 23-Dec-2014 $2.25M $2.25M 00.000 Completed Generating Revenue
1. Grant 01-Dec-2012 $1.75M Completed Generating Revenue
To view microMend’s complete valuation and funding history, request access »

microMend Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B-3 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B-2 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B-1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A1 809,990 $0.000100 $0.9 $0.9 1x $0.9 3.17%
Series A 4,587,757 $0.000100 $0.61 $0.61 1x $0.61 17.97%
To view microMend’s complete cap table history, request access »

microMend Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of wound closure product designed to offer a new alternative to sutures and staples for skin closure. The comp
Medical Supplies
Seattle, WA
13 As of 2023
000.00
0000000000 0 000.00

000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000000 00000000
Houston, TX
0 As of 0000

000000

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
00000000000 0000000
Marlborough, MA
000 As of 0000
0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

microMend Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DermaClip Corporation Houston, TX 0
Candela Medical Private Equity-Backed Marlborough, MA 000 0000 0000000000
FzioMed Venture Capital-Backed San Luis Obispo, CA 00 000.00 00000000000 000.00
OmniGuide Venture Capital-Backed Billerica, MA 00 00000 000000 - 000 00000
Cytrellis Venture Capital-Backed Woburn, MA 00 000.00 00000000000 000.00
You’re viewing 5 of 8 competitors. Get the full list »

microMend Patents

  • 23

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 10

    Granted

  • 10

    Pending

  • 000

    Expiring in next 12 mo

microMend Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230263523-A1 Force modulating deep skin staples and instruments Active 18-Feb-2022 000000000000 0
US-11957346-B2 Force modulating deep skin staples and instruments Active 18-Feb-2022 000000000000 000
US-20240268825-A1 Force modulating deep skin staples and instruments Pending 18-Feb-2022 000000000000
US-20220240935-A1 Wound closure device with wide spaced microstructures Inactive 29-Jan-2021 0000000000
EP-4284258-A1 Wound closure device with wide spaced microstructures Pending 29-Jan-2021 A61B17/064
To view microMend’s complete patent history, request access »

microMend Executive Team (6)

Name Title Board Seat
Ronald Berenson MD Co-Founder, Chief Executive Officer, President and Board Member
Eli Sonkin Chief Financial Officer
John Canady MD Chairman of Scientific Advisory Board & Board Member
You’re viewing 3 of 6 executive team members. Get the full list »

microMend Board Members (9)

Name Representing Role Since
Cameron Pollock Self Board Member 000 0000
Edward Truitt JD Self Chairman 000 0000
Henry Kim Self Board Member 000 0000
Jens Quistgaard Ph.D Self Board Member 000 0000
John Brzezenski Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

microMend Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

microMend Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel Star Ventures Angel Group Minority 000 0000 000000 0
Caygan Capital Hedge Fund Minority 000 0000 000000 0
Denniston Family Office Family Office Minority 000 0000 000000 0
Elevate Capital Venture Capital Minority 000 0000 000000 0
K2X Corporation Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »

Ready to get started?

Request a free trial

microMend FAQs

  • When was microMend founded?

    microMend was founded in 2011.

  • Who is the founder of microMend?

    Ronald Berenson MD and Marco Rolandi Ph.D are the founders of microMend.

  • Who is the CEO of microMend?

    Ronald Berenson MD is the CEO of microMend.

  • Where is microMend headquartered?

    microMend is headquartered in Seattle, WA.

  • What is the size of microMend?

    microMend has 13 total employees.

  • What industry is microMend in?

    microMend’s primary industry is Medical Supplies.

  • Is microMend a private or public company?

    microMend is a Private company.

  • What is microMend’s current revenue?

    The current revenue for microMend is 00000.

  • How much funding has microMend raised over time?

    microMend has raised $16.4M.

  • Who are microMend’s investors?

    Angel Star Ventures, Caygan Capital, Denniston Family Office, Elevate Capital, and K2X are 5 of 21 investors who have invested in microMend.

  • Who are microMend’s competitors?

    DermaClip, Candela Medical, FzioMed, OmniGuide, and Cytrellis are some of the 8 competitors of microMend.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »